Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play

por Sapre, Nikhil, Selth, Luke A.
Publicado 2013

MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4

por Wang, Qingqing, Selth, Luke A., Callen, David F.
Publicado 2017

Data Mining of Small RNA-Seq Suggests an Association Between Prostate Cancer and Altered Abundance of 5′ Transfer RNA Halves in Seminal Fluid and Prostatic Tissues

por Dhahbi, Joseph M, Atamna, Hani, Selth, Luke A
Publicado 2018

Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review

por John, Athul, O'Callaghan, Michael, Catterwell, Rick, Selth, Luke A
Publicado 2020

Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer

por Xie, Jianling, Kusnadi, Eric P., Furic, Luc, Selth, Luke A.
Publicado 2021

Functional Studies of the Yeast Med5, Med15 and Med16 Mediator Tail Subunits

por Larsson, Miriam, Uvell, Hanna, Sandström, Jenny, Rydén, Patrik, Selth, Luke A., Björklund, Stefan
Publicado 2013

Erratum to: IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor

por Carter, Sarah L., Centenera, Margaret M., Tilley, Wayne D., Selth, Luke A., Butler, Lisa M.
Publicado 2016

A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer

por Matin, Farhana, Jeet, Varinder, Moya, Leire, Selth, Luke A., Chambers, Suzanne, Clements, Judith A., Batra, Jyotsna
Publicado 2018

VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer

por Holding, Andrew N., Giorgi, Federico M., Donnelly, Amanda, Cullen, Amy E., Nagarajan, Sankari, Selth, Luke A., Markowetz, Florian
Publicado 2019

Correction to: VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer

por Holding, Andrew N., Giorgi, Federico M., Donnelly, Amanda, Cullen, Amy E., Nagarajan, Sankari, Selth, Luke A., Markowetz, Florian
Publicado 2019

Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors

por Gillis, Joanna L., Selth, Luke A., Centenera, Margaret M., Townley, Scott L., Sun, Shihua, Plymate, Stephen R., Tilley, Wayne D., Butler, Lisa M.
Publicado 2013

Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies

por Chan, Siu Chiu, Selth, Luke A., Li, Yingming, Nyquist, Michael D., Miao, Lu, Bradner, James E., Raj, Ganesh V., Tilley, Wayne D., Dehm, Scott M.
Publicado 2015

The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switchin...

por Need, Eleanor F., Selth, Luke A., Trotta, Andrew P., Leach, Damien A., Giorgio, Lauren, O’Loughlin, Melissa A., Smith, Eric, Gill, Peter G., Ingman, Wendy V., Graham, J. Dinny, Buchanan, Grant
Publicado 2015

Functional Characterisation of the Circular RNA, circHTT(2-6), in Huntington’s Disease

por Gantley, Laura, Stringer, Brett W., Conn, Vanessa M., Ootsuka, Youichirou, Holds, Duncan, Slee, Mark, Aliakbari, Kamelya, Kirk, Kirsty, Ormsby, Rebecca J., Webb, Stuart T., Hanson, Adrienne, Lin, He, Selth, Luke A., Conn, Simon J.
Publicado 2023

Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer

por Hinneh, Josephine A., Gillis, Joanna L., Mah, Chui Yan, Irani, Swati, Shrestha, Raj K., Ryan, Natalie K., Atsushi, Enomoto, Nassar, Zeyad D., Lynn, David J., Selth, Luke A., Kato, Masashi, Centenera, Margaret M., Butler, Lisa M.
Publicado 2023

High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids

por Choo, Nicholas, Ramm, Susanne, Luu, Jennii, Winter, Jean M., Selth, Luke A., Dwyer, Amy R., Frydenberg, Mark, Grummet, Jeremy, Sandhu, Shahneen, Hickey, Theresa E., Tilley, Wayne D., Taylor, Renea A., Risbridger, Gail P., Lawrence, Mitchell G., Simpson, Kaylene J.
Publicado 2021

Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion

por Armstrong, Heather K., Gillis, Joanna L., Johnson, Ian R. D., Nassar, Zeyad D., Moldovan, Max, Levrier, Claire, Sadowski, Martin C., Chin, Mei Yieng, Tomlinson Guns, Emma S., Tarulli, Gerard, Lynn, David J., Brooks, Douglas A., Selth, Luke A., Centenera, Margaret M., Butler, Lisa M.
Publicado 2018

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth

por Gillis, Joanna L, Hinneh, Josephine A, Ryan, Natalie K, Irani, Swati, Moldovan, Max, Quek, Lake-Ee, Shrestha, Raj K, Hanson, Adrienne R, Xie, Jianling, Hoy, Andrew J, Holst, Jeff, Centenera, Margaret M, Mills, Ian G, Lynn, David J, Selth, Luke A, Butler, Lisa M
Publicado 2021

Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis

por Nassar, Zeyad D, Mah, Chui Yan, Dehairs, Jonas, Burvenich, Ingrid JG, Irani, Swati, Centenera, Margaret M, Helm, Madison, Shrestha, Raj K, Moldovan, Max, Don, Anthony S, Holst, Jeff, Scott, Andrew M, Horvath, Lisa G, Lynn, David J, Selth, Luke A, Hoy, Andrew J, Swinnen, Johannes V, Butler, Lisa M
Publicado 2020

Expression of androgen receptor splice variants in clinical breast cancers

por Hickey, Theresa E., Irvine, Connie M., Dvinge, Heidi, Tarulli, Gerard A., Hanson, Adrienne R., Ryan, Natalie K., Pickering, Marie A., Birrell, Stephen N., Hu, Dong Gui, Mackenzie, Peter I., Russell, Roslin, Caldas, Carlos, Raj, Ganesh V., Dehm, Scott M., Plymate, Stephen R., Bradley, Robert K., Tilley, Wayne D., Selth, Luke A.
Publicado 2015